Correction: Girard et al. Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis. Cancers 2024, 16, 2492

By sjmartinez • February 21, 2025

Girard N, Besada M, Rogula B, Lucherini S, Vo L, Chaudhary MA, Goring S, Lozano-Ortega G, Tran M, Varol N, Waser N, Yu WW, Lee JM, Spicer J. Correction: Girard et al. Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis. Cancers 2024, 16, 2492. Cancers (Basel). 2025 Feb 17;17(4):674. doi: 10.3390/cancers17040674. Erratum for: Cancers (Basel). 2024 Jul 08;16(13):2492. doi: 10.3390/cancers16132492. PMID: 39976394.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Related Posts

Dietary control of peripheral adipose storage capacity through membrane lipid remodelling

Tol MJ, Shimanaka Y, Bedard AH, Sapia J, Cui L, Colaço-Gaspar M, Hofer P, Ferrari A, Qian K, Kennelly JP, Lee SD, Gao Y, Xiao[...]

A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancer

Lloyd MR, Chica-Parrado R, Weipert CM, Knepper TC, Podany EL, Napolitano F, Ye D, Lin CC, Uemoto Y, Liao J, Wegrzyn C, Walko CM, Ryan[...]

Vasculopathy, embolism, xerostomia, arthritis, and stomachache

Zhang W, Cai S, Zheng S, Hu S, Zheng K, Lin J, Chen M, Du G, Matucci-Cerinic M, Furst DE, Wang Y. Vasculopathy, embolism, xerostomia,[...]